Chinese firms strengthen focus on development and commercialisation of mRNA vaccines

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...

April 7, 2022 | Thursday | News
Rona Therapeutics raises $33 million in Series A

China-based startup Rona Therapeutics announces the successful completion of $33 million Series A financing to advance p...

April 7, 2022 | Thursday | News
Everest Medicines announces positive results from Chinese subpopulation for NEFECON

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical ...

April 6, 2022 | Wednesday | News
Hong Kong highlights significant global incidence of newly diagnosed type 1 diabetes

One of the largest global studies of its kind, led by The Chinese University of Hong Kong (CUHK)’s Faculty of Medi...

April 6, 2022 | Wednesday | News
Ascletis seeks authorization for Ritonavir in Hong Kong

Ascletis Pharma has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the H...

April 4, 2022 | Monday | News
China approves clinical trial for CanSinoBIO's COVID-19 mRNA vaccine

CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...

April 5, 2022 | Tuesday | News
China backs 'Tai Chi Training' to improve Parkinson's Disease and mild cognitive impairment

The latest research shows that Tai Chi training (an internal Chinese martial art) is conducive to the treatment of Parki...

April 1, 2022 | Friday | News
Zhimeng Biopharma begins Phase I trial of Hep B drug

China's Zhimeng Biopharma, Inc., an innovation-driven biopharmaceutical company focused on the development of innovative...

April 1, 2022 | Friday | News
UMP Healthcare expands free telemedicine and drug delivery to COVID-19 patients

Hong Kong based UMP Healthcare Holdings Limited has announced the results of a recent service survey, which found that a...

April 1, 2022 | Friday | News
JW Therapeutics announces IND approval of Carteyva

China's JW Therapeutics has received the Investigational New Drug (IND) clearance from the National Medical Products Adm...

March 31, 2022 | Thursday | News
CStone starts phase I trial of cancer drug

China's CStone Pharmaceuticals, a leading biopharmaceutical company focused on the research, development, and commercial...

March 31, 2022 | Thursday | News
Hong Kong study links dry eye disease with COVID-19

Some COVID-19 patients develop various and persistent symptoms weeks and months after completely recovering from the inf...

March 31, 2022 | Thursday | News
Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology

China's Biosion, Inc., and US' Pyxis Oncology have entered into an agreement under which Pyxis Oncology will be granted ...

March 30, 2022 | Wednesday | News
CellOrigin raises new funds to Jump-start iPSC immune cell therapy products toward clinics

China's CellOrigin Inc, a biotech company focusing on iPSC-derived immune cell therapies, announced it secured a new rou...

March 30, 2022 | Wednesday | News
China advances commercialisation of long-acting COVID-19 neutralising antibody therapy

Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is p...

March 30, 2022 | Wednesday | News
Taiwan accepts CANbridge's NDA for Alagille Syndrome

CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...

March 29, 2022 | Tuesday | News
China's Biocytogen expands global footprint with opening of innovation centre in Germany

Biocytogen Pharmaceuticals (Beijing) Co., has announced the opening of the Biocytogen Europe Innovation Centre (BEIC) in...

March 29, 2022 | Tuesday | News
InnoCare announces approval of Clinical Trial of TYK2 JH2 allosteric Inhibitor ICP-488 in China

InnoCare Pharma has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical P...

March 28, 2022 | Monday | News
China's Innovent Biologics expands oncology partnership with Eli Lilly for $45M

Innovent Biologics and Eli Lilly and Company have announced that the companies will now expand the strategic partnership...

March 28, 2022 | Monday | News
Chinese startup iMeddy provides free video medical consultation to COVID-19 patients

Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University...

March 25, 2022 | Friday | News
Insilico Medicine partners with EQRx for AI-driven drug discovery

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...

March 25, 2022 | Friday | News
Hong Kong builds 'Rehab 8 Forms' programme to aid post-COVID-19 recovery

After two years of battling the COVID-19 pandemic, the World Health Organization (WHO) has suggested that while most peo...

March 24, 2022 | Thursday | News
CARsgen begins phase II trial of CAR-T therapy in China

CARsgen Therapeutics, a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies...

March 24, 2022 | Thursday | News
VivaVision Biotech announces positive results of phase 2 study for treatment of dry eye disease

VivaVision Biotech, Inc. (VivaVision), an ophthalmic pharmaceutical developer focusing on discovery and development of i...

March 23, 2022 | Wednesday | News
China approves first thermal vapour energy system for COPD treatment

Broncus has announced that the company's thermal vapour treatment system InterVapor has been granted approval by the Nat...

March 22, 2022 | Tuesday | News
Transcenta partners with BMS

Transcenta Holding Limited, a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...

March 22, 2022 | Tuesday | News
OBiO Technology announces IPO

OBiO Technology has completed its initial public offering ("IPO") process and started trading on the Shanghai Stock...

March 22, 2022 | Tuesday | News
Bavarian Nordic partners with Nuance Pharma for RSV Vaccine in Asian markets

Denmark's Bavarian Nordic has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-base...

March 21, 2022 | Monday | News
Zai Labs appoints Josh Smiley as Chief Operating Officer

China-based Zai Lab Limited has announced the appointment of Josh Smiley as its Chief Operating Officer (COO). Smiley br...

March 21, 2022 | Monday | News
China's Triastek and Siemens to accelerate digital transformation of pharma industry

Triastek, Inc. and Siemens Ltd., China have signed a strategic collaboration agreement to provide digital tech...

March 18, 2022 | Friday | News
HitGen partners with Howard Hughes Medical Institute and Duke University

HitGen has entered into a research collaboration agreement with Howard Hughes Medical Institute ("HHMI") and Duke Univer...

March 18, 2022 | Friday | News
HiRO raised Tens of Millions of US Dollars in Series A Financing

Harvest Integrated Research Organization (HiRO) has announced the completion of its Series A financing in the tens of mi...

March 18, 2022 | Friday | News
Lynk Pharmaceuticals and Simcere partner for novel JAK1 inhibitor LNK01001

Lynk Pharmaceuticals and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 ...

March 18, 2022 | Friday | News
China's SyMap targets renal denervation with novel 'map-and-ablate' technology

SyMap Medical is developing a selective map-and-ablate technology that has the potential to substantially improve outcom...

March 17, 2022 | Thursday | News
Ping An Good Doctor reports revenue of RMB7,334 Million in 2021

Ping An Healthcare and Technology Company Limited (Ping An Good Doctor) has announced its 2021 annual results. During th...

March 16, 2022 | Wednesday | News
Emerging Trends in Biopharma Deal-Making

Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, ...

March 15, 2022 | Tuesday | News
Adlai Nortye appoints Dr. Victoria Demby as Sr. VP of Global Regulatory Affairs

Adlai Nortye Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies,...

March 15, 2022 | Tuesday | News
Chinese startup MediLink Therapeutics closes $70 M Series B financing

MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) has announced completion of a $70million Series B financing. Thi...

March 15, 2022 | Tuesday | News
G-NiiB launches the world’s first anti-viral Gut Microbiome formula in Singapore

GenieBiome (G-NiiB), a biotechnology spin-off of The Chinese University of Hong Kong (CUHK), announces the launch of G-N...

March 15, 2022 | Tuesday | News
China fights against COVID-19 with traditional medicine and comprehensive care

Hong Kong Baptist University (HKBU) has established a transdisciplinary team of experts and supporting personnel to...

March 14, 2022 | Monday | News
Eucure Biopharma starts Phase I trial of YH002 (Anti-OX40 mAb)

Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I multi-r...

March 14, 2022 | Monday | News
Impact Therapeutics announces completion of series D1 financing

IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer ther...

March 14, 2022 | Monday | News
Hexvix obtained CDE approval for the inclusion in the clinical real-world evidence pilot study

Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovativ...

March 14, 2022 | Monday | News
Pulnovo Medical appoints Jessie Lian Jia as New CEO

Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Jessie Lia...

March 11, 2022 | Friday | News
China's Gan & Lee Pharma begins first-in-human trial for diabetes drug

Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...

March 11, 2022 | Friday | News
Hong Kong-based Insilico Medicine focuses on discovery of potential therapeutics for Cystinosis

The MIKADO group, a translational team at the University of Zurich (UZH) focused on generating evidence-driven...

March 10, 2022 | Thursday | News
Hong Kong study finds that smoking increases risk of COVID-19

Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...

March 9, 2022 | Wednesday | News
China's SeekIn gets CE Mark approval for SeekInCare Pan Cancer early detection test

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...

March 8, 2022 | Tuesday | News
China approves phase II trial of Akeso's cancer drug

Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...

March 8, 2022 | Tuesday | News
WuXi ATU announces launch of TESSA Technology

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...

March 8, 2022 | Tuesday | News
Singleron extends reach outside China, strengthens expertise in translational & clinical research

Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platf...

March 8, 2022 | Tuesday | News
AnchorDx appoints Dr. Marina Bibikova as Chief Scientific Officer

AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...

March 7, 2022 | Monday | News
111, Inc & Beilin Pharma lay focus on digital marketing of Chinese patent medicines

111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...

March 7, 2022 | Monday | News
I-Mab receives FDA orphan drug designation for cancer drug

China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...

March 4, 2022 | Friday | News
China-based startup InxMed raises $50 M in Series B Financing

InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...

March 4, 2022 | Friday | News
Overland Pharmaceuticals Appoints Dr. Xun Liu as Chief Technology Officer

Overland Pharmaceuticals, a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worl...

March 3, 2022 | Thursday | News
China's Adagene partners with French firm Sanofi for Immuno-Oncology

China's Adagene,  a company transforming the discovery and development of antibody-based therapies, has announced a...

March 3, 2022 | Thursday | News
China approves Phase II clinical trial of InnoCare's cancer drug

InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...

March 3, 2022 | Thursday | News
IASO Bio strengthens manufacturing of CAR-T cell therapy products in China

IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing i...

March 2, 2022 | Wednesday | News
Huadong becomes strategic partner in Asia for Heidelberg Pharma, strikes deal worth $0.9B

German firm Heidelberg Pharma AG and Huadong Medicine in China have entered into a strategic partner...

March 1, 2022 | Tuesday | News
China's CANbridge offers treatment for rare liver disease Alagille Syndrome

CANbridge Pharmaceuticals, Inc. has announced that CAN108 (maralixibat), a treatment for Alagille syndrome (ALGS), has b...

February 28, 2022 | Monday | News
Prenetics, ACON Bio to launch Flowflex COVID-19 at-home test in Hong Kong

Prenetics Group has partnered with ACON Bio to launch the Flowflex SARS-CoV-2 Antigen Rapid Test Kit in Hong Kong. ...

February 25, 2022 | Friday | News
Peli BioThermal opens first network station in China

Peli BioThermal, the life science industry’s cold chain partner from discovery to distribution, announces the open...

February 24, 2022 | Thursday | News
China approves world first clinical trial for 3D bio-printed stem cell vascular grafts

Revotek has received clearance from the National Health Commission of China to begin a clinical study in the W...

February 22, 2022 | Tuesday | News
China approves CanSinoBIO's Convidecia as heterologous booster for COVID-19

CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...

February 21, 2022 | Monday | News
Hong Kong finds new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

A study led by The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) and the LKS Faculty of Med...

February 18, 2022 | Friday | News
Catalent expands temp-controlled clinical supply capabilities in China

US-based Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize develop...

February 16, 2022 | Wednesday | News
China gives conditional approval to Pfizer's oral COVID-19 drug

China's drug regulator National Medical Products Administration (NMPA) has granted conditional approval for the imports ...

February 15, 2022 | Tuesday | News
Hong Kong launches first handheld COVID-19 nucleic acid test

Pluslife Biotech, an enterprise based in the Greater Bay Area in Hong Kong, has launched the first handheld COVID-19 Nuc...

February 14, 2022 | Monday | News
China expands collaboration to develop COVID-19 multi-variant vaccine

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, has announced that it will expand its collaborat...

February 10, 2022 | Thursday | News
Hong Kong suggests mRNA vaccinations to tackle COVID-19 variants

Researchers at AIDS Institute, Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMe...

February 9, 2022 | Wednesday | News
China reports better antibody production with intradermal vaccination than intramuscular

Intradermal COVID-19 vaccination studies are emerging in a global effort to multiply available doses by harnessing skin ...

February 8, 2022 | Tuesday | News
Beroni Group sets up new R&D centre in China

Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati...

February 3, 2022 | Thursday | News
Hong Kong identifies potential biomarker for early diagnosis of liver cancer

A research team at the Department of Pathology, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) in collabo...

February 2, 2022 | Wednesday | News
Hong Kong examines eye health in school children, finds myopia deepening faster

Two research teams from The Hong Kong Polytechnic University (PolyU) found that not only did the rate of myopia progress...

January 31, 2022 | Monday | News
Eastern Asia’s lung cancer incidence and mortality highest in world: Study

Lung cancer is the most common cancer and the most common cause of cancer death in Hong Kong. Researchers from The Chine...

January 28, 2022 | Friday | News
ENDRA Life Sciences expands into China with Shanghai General Hospital partnership

US-based ENDRA Life Sciences Inc. has received Institutional Review Board approval from China’s Shanghai...

January 25, 2022 | Tuesday | News
WuXi STA launches first parenteral formulation manufacturing line in China

WuXi STA, a subsidiary of WuXi AppTec, has announced that its first parenteral formulation manufacturing line ...

January 24, 2022 | Monday | News
Gene therapy CDMO GenScript ProBio to expand manufacturing facility in China

GenScript ProBio, a global antibody and gene therapy contract development and manufacturing organization (CDMO), has ann...

January 21, 2022 | Friday | News
Industrial chemical Bisphenol S increases cancer risk: China study

A study led by Hong Kong Baptist University (HKBU) has revealed that different degrees of exposure to bisphenol S (BPS),...

January 20, 2022 | Thursday | News
China approves world's first artificial cornea of 100% non-biological materials

MIOK Keratoprosthesis has been approved for listing by National Medical Products Administration (NMPA), the Chinese agen...

January 19, 2022 | Wednesday | News
Agilent expands manufacturing capacity in Shanghai

Agilent Technologies has announced plans to invest $20 million to expand its Shanghai manufacturing center to meet growi...

January 18, 2022 | Tuesday | News
Hong Kong develops anti-virus 3D printing material to rapidly terminate COVID-19

An interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) has successfully developed the worl...

January 17, 2022 | Monday | News
United Imaging invests $0.5 B for ‘Intelligent R&D Complex’ in China

The construction of United Imaging's brand new Manufacturing and R&D base of operations officially kicked off. With ...

January 14, 2022 | Friday | News
Hong Kong dissects lung carcinoma at single-cell resolution uncovering new mechanism

Tumour formation is a multistep and complex process and the underlying mechanism behind it is still largely unclear. A n...

January 13, 2022 | Thursday | News
China-based Fosun Pharma and Insilico Medicine advance AI-driven drug discovery

Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...

January 12, 2022 | Wednesday | News
China approves Medtronic TAVR system for patients with symptomatic severe aortic stenosis

Medtronic has announced that the National Medical Products Administration (NMPA) has approved the CoreValve™ Evolu...

January 11, 2022 | Tuesday | News
China proposes action plan to focus on disability prevention

China is planning to strengthen disability prevention efforts by promoting premarital healthcare and healthy lifestyles,...

January 10, 2022 | Monday | News
“We want to work with global innovation leaders in disruptive technologies”

A company’s agile structure depends on creating a network of scientific advisors and venture partners to accelerat...

January 6, 2022 | Thursday | News
Biosyngen launches production base for immune cell therapeutics in China

The inauguration ceremony of Biosyngen joint projects and Biosyngen biological production base was held recently in ...

January 4, 2022 | Tuesday | News
China's Ascletis expands Ritonavir oral tablet production for COVID-19

Ascletis Pharma Inc., based in China, has announced the expansion of the production of ritonavir oral tablets and oral d...

January 3, 2022 | Monday | News
China designs injectable, adhesive surgical gel to prevent scar tissue

Up to 90% of patients who undergo open abdominal or pelvic surgery develop postoperative adhesions, or scar tissue. Mini...

January 1, 2022 | Saturday | News
China’s BeiGene expands collaboration with Novartis for oncology medicines

China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...

December 28, 2021 | Tuesday | News
Hong Kong establishes Centre for Chinese Herbal Medicine Drug Development

Hong Kong Baptist University (HKBU) has established the Centre for Chinese Herbal Medicine Drug Development (CDD), which...

December 27, 2021 | Monday | News
China approves Yiling Pharma's patent depression-resolving drug

Yiling Pharmaceutical's depression-resolving and restlessness-relieving capsules have been approved for marketing via th...

December 24, 2021 | Friday | News
Hong Kong develops first anti-COVID-19 stainless steel

A team of researchers at the Department of Mechanical Engineering of the Faculty of Engineering of the University of Hon...

December 23, 2021 | Thursday | News
China introduces whole course management system for osteoporosis patients

Ping An Healthcare and Technology Company has entered into a strategic partnership with a leading Japanese pharmaceutica...

December 22, 2021 | Wednesday | News
BeiGene Bioisland Innovation Centre opens in China

BeiGene has announced the official launch of the BeiGene Bioisland Innovation Centre (BIC) in Guangzhou, China to enable...

December 21, 2021 | Tuesday | News
China advances smart health application with AI

SenseTime, a leading global artificial intelligence (AI) software company, has formed a strategic partnership with Kiang...

December 17, 2021 | Friday | News
China-based LifeTech strengthens partnership with Medtronic for pacemakers

LifeTech Scientific Corporation has extended its agreements with Medtronic to further the strategic collaboration on the...

December 16, 2021 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls